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Abstract
 
Perichondrium in fetal limb is composed of undifferentiated mesenchymal cells. However, the
multipotency of cells in this region and the role of perichondrium in bone marrow formation
are not well understood. In this report, we purified and characterized perichondrial cells using
a monoclonal antibody against activated leukocyte cell adhesion molecule (ALCAM) and in-
vestigated the role of perichondrial cells in hematopoietic bone marrow formation. ALCAM is
expressed on hematopoietic cells, endothelial cells, bone marrow stromal cells, and mesenchy-
mal stem cells and mediates homophilic (ALCAM–ALCAM)/heterophilic (ALCAM-CD6)
cell adhesion. Here we show by immunohistochemical staining that ALCAM is expressed in
perichondrium. ALCAM
 
 
 
 perichondrial cells isolated by FACS
 
®
 
 exhibit the characteristics of
mesenchymal stem cells. ALCAM
 
 
 
 cells can differentiate into osteoblasts, adipocytes, chondro-
cytes, and stromal cells, which can support osteoclastogenesis, hematopoiesis, and angiogenesis.
Furthermore, the addition of ALCAM-Fc or CD6-Fc to the metatarsal culture, the invasion of
the blood vessels to a cartilage was inhibited. Our findings indicate that ALCAM
 
 
 
 perichon-
drial cells participate in vascular invasion by recruiting osteoclasts and vessels. These findings
suggest that perichondrium might serve as a stem cell reservoir and play an important role in
the early development of a bone and bone marrow.
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Introduction
 
Development, remodeling, and regeneration of tissue and
organs are dependent on the activity of stem cells. Bone for-
mation in fetal stages, especially endochondral ossification,
 
begins with aggregation of mesenchymal stem cells (MSCs)
 
*
 
to form condensations (1). In the core of mesenchymal con-
densation, cells differentiate into chondrocytes. However,
in the periphery of such condensations, undifferentiated
mesenchymal cells form the perichondrium (which is then
called periosteum; reference 2). At the time when chondro-
cyte hypertrophy occurs, the perichondrial cells differentiate
into osteoblasts to form the bone collar (3). Just after the
calcification of this bone collar, blood vessels penetrate it
and the cartilage, bringing the blood supply that will form
the hematopoietic bone marrow (BM; reference 4).
In adult stages, MSCs contribute to the maintenance of
various tissues. It has been reported that MSCs can be iso-
lated from adult BM (5) and can be induced in vitro and in
vivo to differentiate into a variety of mesenchymal tissues
such as bone, cartilage, muscle, ligament, tendon, adipose
tissue, and stroma. In addition, human BM-derived MSCs
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-glycerol phosphate; ALCAM,
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Ang, angiopoietin; bFGF, basic fibroblast growth factor; BM, bone mar-
row; Epo, erythropoietin; HSC, hematopoietic stem cell; ICAM, intra-
cellular cell adhesion molecule; LMC, limb mononuclear cell; MSC,
mesenchymal stem cell; PDGF, platelet-derived growth factor; P-Sp,
paraaortic splanchnopleural mesoderm; SCF, stem cell factor; SP, side
population; TRAP, tartrate-resistant acid phosphatase; VEGF, vascular
endothelial growth factor. 
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can maintain their multipotential capacity and exhibit site-
specific differentiation after in utero transplantation in
sheep (6). MSCs derived from adult BM has been well
characterized and analyzed for its ability to differentiate,
whereas it is still unclear how MSCs contribute to in vivo
embryonic tissue formation (organogenesis), such as bone
and BM. Previous studies indicate that perichondrium con-
tains immature mesenchymal cells and plays a critical role
of bone formation (2, 7, 8). Moreover, it is reported that a
population of small, relatively agranular cells isolated from
fetal rat perichondrium display stem cell characteristics (9).
However, evidence supporting multipotency of cells de-
rived from perichondrium has been insufficient.
Recently, several cell surface markers expressed on mar-
row-derived MSCs have been identified. It has been re-
ported that activated leukocyte cell adhesion molecule
(ALCAM; CD166) is expressed on MSCs (5, 10). This ex-
pression disappears once the MSCs embark on an osteo-
genic pathway and begin to express alkaline phosphatase
(ALP). These observations indicate that ALCAM may play
a role in the progress of osteogenic differentiation, al-
though the precise mechanism of that activity remains to
be elucidated (10).
ALCAM was first identified on thymic epithelial cells
(11) and activated leukocytes (12). ALCAM is a member of
the Ig superfamily and contains five extracellular Ig do-
mains. It is a highly glycosylated type I transmembrane
molecule with a short (32-aa) cytoplasmic tail and an ob-
served molecular mass of 105 kD, and it mediates ho-
mophilic/heterophilic adhesion (ALCAM-CD6; reference
12). ALCAM-mediated homophilic cell adhesion is tightly
regulated through the actin cytoskeleton by the formation
of clusters of molecules at the cell surface (13). Uchida et al.
(14) identified hematopoietic cell antigen, which is identi-
cal to ALCAM, on hematopoietic stem cells (HSCs) and
myeloid progenitors. ALCAM is highly homologous to a
neuronal protein known as DM-GRASP/SC-1/BEN in
chick (15–17), KG-CAM in rat (18), and neurolin in gold-
fish (19). In addition to being expressed on MSCs and he-
matopoietic cells, ALCAM is expressed on metastasizing
melanoma (20), neuronal cells (16), endothelial cells (21),
and hematopoiesis-supporting osteoblastic cells (22). AL-
CAM is also expressed by subsets of stromal cells in the pri-
mary hematopoietic sites that sequentially develop in the
human embryo and fetus, i.e., the paraaortic mesoderm,
liver, thymus, and BM (23).
In this report, we analyzed the differentiation ability of
perichondrial cells, which can be isolated by FACS
 
®
 
 using
anti-ALCAM mAb. Furthermore, we investigated the role
of cell–cell adhesion through ALCAM in vascular invasion
to the cartilage, and clarified how perichondrium contrib-
utes to bone and BM development.
 
Materials and Methods
 
Mice.
 
Pregnant C57BL/6 mice were purchased from Japan
SLC. Embryos at E13.5 were used to dissect the limb, and em-
bryos at E17.5 were used to dissect the metatarsals of hindlimb.
 
Antibodies.
 
The mAbs were used in this study: anti–CD31/
PECAM-1; anti-CD45 antibody, anti-
 
 
 
1 integrin; anti-
 
 
 
4 inte-
grin; anti-
 
 
 
5 integrin; anti-
 
 
 
v integrin; anti-
 
 
 
3 integrin; anti–
intracellular cell adhesion molecule (ICAM)-1; anti–ICAM-2;
anti-CD44; anti-Endoglin; anti–platelet-derived growth factor
(PDGF) receptor 
 
 
 
 chain; anti–Thy-1; anti-CD34; anti–c-Kit;
anti-CD4; anti-CD8; anti-B220, anti–TER-119; anti–Gr-1; and
anti–Mac-1. All were purchased from BD PharMingen. The pro-
duction of the anti-ALCAM mAb was described previously (21).
 
Immunohistochemistry.
 
For histological analysis, dissected fore-
limbs were fixed 2 h in 4% paraformaldehyde at 4
 
 
 
C, rinsed in
PBS, dehydrated through a methanol series, embedded in polyes-
ter wax, and sectioned at 8 
 
 
 
m. The procedure for immunohis-
tochemistry of tissue sections was as described previously (24). An
anti-ALCAM mAb and an anti–PECAM-1 mAb were used in
this assay. The primary antibody was developed with horseradish
peroxidase-conjugated anti–rat Ig antibody (Biosource).
 
Cell Preparation and Cell Sorting.
 
Dissected limbs were incu-
bated with 2.4 U Dispase
 
®
 
 (GIBCO BRL) in PBS at 37
 
 
 
C for
60 min and passed through a 23 G needle. Dispersed cells were
washed with DMEM-low glucose (GIBCO BRL) containing
10% FCS (JRH Bioscience). Mononuclear cells were isolated by
centrifugation of total limb mononuclear cells (LMCs) on Lym-
phoprep™ (NYCOMED PHARMA AS.) according to the
manufacturer’s instructions. The cell-staining procedure for
flow cytometry was as described previously (25). The stained
cells were analyzed and sorted by FACSvantage™ (Becton
Dickinson).
To identify and isolate side population (SP) cells from LMCs,
the cells were suspended at 10
 
6
 
 cells per ml in 2% FCS/DMEM
(staining medium) and preincubated at 37
 
 
 
C for 10 min. The cells
were then labeled with 2.5 
 
 
 
g/ml Hoechst 33342 (Molecular
Probes) in staining medium at 37
 
 
 
C for 90 min. Verapamil
(Sigma-Aldrich) was used at 50 
 
 
 
M and included in the entire
Hoechst staining procedure.
 
Cell Culture.
 
Fractionated and unfractionated cells were
maintained in 10% FCS/DMEM low glucose at 37
 
 
 
C in humid-
ified 5% CO
 
2
 
 air. Inductions of osteogenic and adipogenic dif-
ferentiation were performed according to the report of Pittenger
et al. (5). The procedures for chondrogenic differentiation were
described previously (26, 27). For osteogenic induction, cells
were cultured for 2 wk in 10% FCS/DMEM low glucose in the
presence of 10 mM 
 
 
 
-glycerol phosphate (
 
 
 
-GP; Sigma-Aldrich)
and 50 
 
 
 
M ascorbic acid (Sigma-Aldrich). Osteoblastic differen-
tiation was evaluated by ALP staining and ALP enzymic activity.
Calcium deposition was stained with 1% alizarin red. ALP stain-
ing was performed using a histochemical kit (no. 85; Sigma-
Aldrich) according to the manufacturer’s instructions. ALP ac-
tivity was measured by a diagnostic kit (no. 245; Sigma-Aldrich).
For adipogenic induction, cells were cultured with 0.5 mM
3-isobutyl-1-methylxanthine (IBMX) and 1 
 
 
 
M Dex, 10 mg/ml
insulin, and 10% FCS in DMEM low glucose (MDI medium:
adipogenic induction medium). After 1 wk of cultivation, media
was changed to adipogenic maintenance medium (10% FCS/
DMEM low glucose containing 1 
 
 
 
M Dex and 10 mg/ml insu-
lin) for an additional 7 d. Adipogenic differentiation was exam-
ined by the accumulation of lipid vesicles using a fluorescence
assay based on Nile red staining. Chondrogenic potential was
assayed by culturing cells in 10% FCS/DMEM low glucose
containing 1 
 
 
 
g/ml rh-BMP-2 (a gift from Yamanouchi Phar-
maceutical Co., Tokyo, Japan) for 2 wk at 37
 
 
 
C in humidified
5% CO
 
2
 
 air. After cultivation, cells were stained with alcian
blue (28). 
1551
 
Arai et al.
 
For blocking of ALCAM–ALCAM interaction, recombinant
human ALCAM/human IgG
 
1
 
 Fc chimeric protein (ALCAM-Fc;
R&D Systems) or recombinant mice CD6/human IgG1 Fc chi-
meric protein (CD6-Fc; R&D Systems) were added to the in
vitro cultivation. CD4-Fc was used for control-Fc.
 
In Vitro Osteoclastogenesis.
 
BM-derived osteoclast precursor
cells (25) were cocultured with ALCAM
 
high
 
 cells. Cultures were
maintained in 
 
 
 
-MEM/10% FCS with 10
 
 
 
8
 
 M 1,25-(OH)
 
2
 
D
 
3
 
and 10
 
 
 
7
 
 M dexamethasone (Dex). Tartrate-resistant acid phos-
phatase (TRAP) staining and measurement of TRAP-activity
were performed on day 7 of coculture. Procedures used for
TRAP staining and analysis of TRAP activity were described
previously (25).
 
In Vitro Hematopoiesis.
 
BM-derived HSCs and fractionated
limb-derived cells were cocultured in 10% FCS/RPMI 1640
(GIBCO BRL) containing 10
 
 
 
5
 
 M 2ME (GIBCO BRL), 20 ng/
ml IL-6 (PeproTech), 50 U/ml IL-7 (PeproTech), 50 ng/ml
stem cell factor (SCF; R&D Systems), and 2 U/ml Erythropoi-
etin (Epo) (a gift from Snow-Brand Milk Products, Tochigi, Ja-
pan) at 37
 
 
 
C in humidified 5% CO
 
2
 
 air. After 10 d of cultivation,
expanded number of CD45
 
 
 
 cells were counted and the expres-
sion of c-Kit and lineage markers were analyzed by FACS
 
®
 
.
 
In Vitro Angiogenesis.
 
E9.5 mouse paraaortic splanchnopleural
mesoderm (P-Sp)-derived cells were used as endothelial precursor
cells. These cells were cocultured with ALCAM
 
high
 
 cells in the
presence or absence of 10 ng/ml vascular endothelial growth fac-
tor (VEGF) for 10 d. Before cocultivation, ALCAM
 
high
 
 cells were
induced or not induced to undergo mesenchymal lineage-specific
differentiation (osteo-, adipo-, and chondrogenic differentiation).
After cocultivation, cells were fixed and stained with anti–PE-
CAM-1 mAb.
 
Metatarsal Culture.
 
Metatarsal culture was performed as de-
scribed previously (29, 30). In brief, the three middle metatarsals
of each hindlimb of E17.5 embryo were dissected and cultured
for 5 d on Millicell
 
®
 
 culture plate insert (Millipore) on 1 ml of
BGJb medium (GIBCO BRL) supplemented with 10% FCS.
Control-Fc, ALCAM-Fc, or CD6-Fc was added to a final con-
centration of 20 
 
 
 
g/ml. After cultivation, metatarsals were fixed
and processed for polyester wax sections. Each section was stained
with anti–PECAM-1 MoAb.
 
RT-PCR Analysis.
 
Isolated RNA was reverse transcribed us-
ing an RT-PCR kit (CLONTECH). The cDNAs were ampli-
fied using an Advantage polymerase mix (CLONTECH) in a Ge-
neAmp PCR system model 9700 (Perkin-Elmer) for 25–30
cycles. Sequences of gene specific primers for RT-PCR were as
follows: 5
 
 
 
-angiopoietin (Ang)-1 (CAGTGGCTGCAAAAACT-
TGA); 3
 
 
 
-Ang-1 (TCTGCACAGTCTCGAAATGG); 5
 
 
 
-Ang-2
(CACACTGACCTTCCCCAACT); 3
 
 
 
-Ang-2 (TGGTGTCT-
CTCAGTGCCTTG); 5
 
 
 
-VEGF (CTTTACTGCTGTACCT-
TCACCATGC); 3
 
 
 
-VEGF (AACAAGGCTCACAGTGATT-
TTCTGG); 5
 
 
 
-basic fibroblast growth factor (bFGF) (CCC-
AAGCGGCTCTACTGCAAGAAC); 3
 
 
 
-bFGF (GGTCCCG-
TTTTGGATCCGAGTTTAT); 5
 
 
 
-ChM-1 (CACAAGAAGA-
CCACACAGCGAACCT); 3
 
 
 
-ChM-1 (CTTTCAGCACAT-
TTGCACACAGTGG); 5
 
 
 
-mOC: TAGTGAACAGACTCCG-
GCGCTACCTT; 3
 
 
 
-mOC: AGCTCGTCACAAGCAGGGT-
TAAGCTC; 5
 
 
 
-PPAR
 
 
 
: GCTGATGCACTGCCTATGAGC-
ACTT; 3
 
 
 
-PPAR
 
 
 
: GAAGCCTGATGCTTTATCCCCACAG;
5
 
 
 
-mSOX9: GGAAGATAAGTTCCCCGTGTGCATC; 3
 
 
 
-
mSOX9: ATGTGAGTCTGTTCCGTGGCCTCTT; 5
 
 
 
-mcol2:
CAGAAAGGAGAACCTGGAGATATCA; 3
 
 
 
-mcol2: TCTC-
CCTTGTCACCACGATCACCTC; 5
 
 
 
-mG3PDH (TGAAG-
GTCGGTGTGAACGGATTTGGC); and 3
 
 
 
-mG3PDH (CAT-
 
GTAGGCCTAGAGGTCCACCAC). Each cycle consisted of
30 s denaturation at 94
 
 
 
C, and 4 min annealing/extension at
70
 
 
 
C.
 
Results
 
Purification of ALCAM-Positive Perichondrial Cells.
 
To
investigate the expression of ALCAM at the site of endo-
chondral ossification, we analyzed the ALCAM expression
pattern by immunohistochemistry. In E13.5 limb, high lev-
els of ALCAM expression were restricted to the periphery
of cartilage (perichondrium) (Fig. 1 A a and b; black arrow-
heads). In addition, ALCAM
 
 
 
 endothelial cells were dis-
tributed in the direction of the midshaft of cartilage (Fig. 1
A a–c; arrows). PECAM-1
 
 
 
 endothelial cells were seen
close to the ALCAM
 
 
 
 perichondrium (Fig. 1 A c and d).
FACS
 
®
 
 analysis showed the proportion of PECAM-1
 
 
 
CD45
 
 
 
ALCAM
 
 
 
 cells was 8.2 
 
 
 
 2.5% in freshly prepared
LMCs. After 2 d of cultivation, the percentage of PECAM-
1
 
 
 
CD45
 
 
 
ALCAM
 
high 
 
cells increased to 87.4 
 
 
 
 4.0% (Fig.
1 B). For further analysis, total LMCs were precultured for
2 d and PECAM-1
 
 
 
CD45
 
 
 
ALCAM
 
high 
 
(hereafter AL-
CAM
 
high
 
) and PECAM-1
 
 
 
CD45
 
 
 
ALCAM
 
low/
 
 
 
 (hereafter
ALCAM
 
low/
 
 
 
) cells were sorted and used for a mesenchy-
mal differentiation assay. Both ALCAM
 
high
 
 cells and AL-
CAM
 
low/
 
 
 
 cells were spreading on the dish, and the re-
markable difference was not seen in 12 h after plating. After
4 d of cultivation, in the ALCAM
 
low/
 
  cells, the number of
swollen cells were increased as cultivation progressed (Fig.
1 C c). ALCAMhigh cell seemed to be a homogeneous pop-
ulation in shape (Fig. 1 C d). These data suggest that cells
in perichondrium region express ALCAM and that AL-
CAM expression could be useful for isolation of a peri-
chondrium fraction.
Characterization of Limb-derived ALCAMhigh Cells. AL-
CAM expression was increased in LMCs after 2 d of culti-
vation as shown in Fig. 1 B. There are two possibilities for
such an increase in ALCAM expression. One is that
ALCAM  cells have a higher proliferation activity than
ALCAM  cells in freshly prepared LMCs, and the other is
that freshly isolated ALCAM  cells express ALCAM. To
differentiate between these two possibilities we compared
cell growth between ALCAM  and ALCAM  cells that
were sorted from freshly prepared LMCs. The expanded
cell number derived from freshly isolated ALCAM  cells
was 2.5 times greater than from freshly isolated ALCAM 
cells after 4 d of cultivation (Fig. 2 A). Then, to know
whether the cell adhesion through ALCAM regulate cell
growth, we added ALCAM-Fc and CD6-Fc to cultivation
of ALCAM  cells, and examined those effects on cell pro-
liferation. Fig. 2 B a shows the comparison of cell prolifera-
tion among the cells cultured in the presence of control-Fc,
ALCAM-Fc, or CD6-Fc. Fig. 2 B b shows the comparison
of the number of cells in each experimental day. The num-
ber of adherent cells in 0.5 d after plating did not have the
difference in each group, indicating that ALCAM-Fc and
CD6-Fc did not inhibit initial cell attachment. In the fifth
day of cultivation, as compared with the cells that added1552 Role of Perichondrial Stem Cells in Bone and Bone Marrow Formation
control-Fc, the number of the expanded cells was re-
duced  33.3   12.5% and 56.0   7.7% by the addition
of 20  g/ml ALCAM-Fc and 20  g/ml CD6-Fc, re-
spectively (Fig. 2 B). These data suggest that ALCAM is
working to support the cell proliferation in perichon-
drium. Next, we showed that freshly isolated ALCAM 
cells from LMCs became to express ALCAM in the cul-
ture. After cultivation, 62.8   5.0% and 88.2   1.6% of
the cells expressed ALCAM on days 2 and 6, respectively
(Fig. 2 C).
Figure 1. Perichondrial cells express ALCAM. (A) Lon-
gitudinal sections of E13.5 forelimb were stained with
anti-ALCAM mAb (a and b) and anti–PECAM-1 mAb (c
and d). ALCAM  cells (black arrowheads) are seen in the
perichondrium region. PECAM-1  endothelial cells
(white arrowheads) were detected surrounding cartilage
and ALCAM-expressing perichondrium. ALCAM  endo-
thelial cells distributed toward the perichondrium (allows).
b and d are higher magnifications of enclosed boxes in a
and c, respectively. Scale bar, 100  m. (B) LMCs derived
from E13.5 limb were stained with anti-CD45, anti–
PECAM-1, and anti-ALCAM mAbs and then fractionated
by FACS®. PECAM-1  cells were gated and examined for
expression of CD45 and ALCAM by contour blot. The
percentages of ALCAM  cells are representative of tripli-
cate experiments. (C) Morphology of sorted ALCAMhigh (a
and b) and ALCAMlow/  cells (c and d). (a and c) 12 h after
plating. (b and d) 4 d after plating. Scale bar, 50  m.1553 Arai et al.
To further characterize ALCAMhigh cells, we analyzed
the expression of several cell surface markers, which were
known to be expressed ( 1,  5,  v,  3 integrins, ICAM-1,
PDGFR, Endoglin, CD44, and Thy-1) or not expressed
( 4 integrin, ICAM-2, and CD34) in human BM-derived
MSCs (5). As shown in Fig. 2 D, ALCAMhigh cells ex-
pressed  1,  5,  v,  3 integrins, ICAM-1, PDGFR, and
CD44 but did not express CD49d, ICAM-2, and CD34.
These expression patterns suggest that ALCAMhigh cells
represent a fairly homogeneous population at least for  1,
 5,  v,  3 integrins, ICAM-1, PDGFR, and CD44.
ALCAM Expression in the Limb SP Cell Fraction. To
analyze ALCAM expression on stem cell fraction in limb
bud, we examined limb SP cells. SP cells are known to be
pluripotent stem cells. To identify SP cells in the limb, ini-
tial studies were conducted to establish optimal Hoechst
dye staining conditions (data not shown). Incubation of
LMCs with 2.5  g/ml of Hoechst 33342 for 90 min con-
sistently identified a population similar to that of murine
BM SP cells (Fig. 3 A a, and data not shown). SP cells rep-
resented 0.58   0.37% in freshly prepared LMCs. Goodell
et al. had previously shown that the Hoechst SP profile in
murine BM was blocked by staining in the presence of ver-
apamil, indicating that the faint staining of SP cells was at
least partially due to the efflux of Hoechst dye mediated by
ABC transporters (31). Hoechst staining of LMCs was also
sensitive to verapamil (Fig. 3 A b). The percentages of
ALCAM  cells in PECAM-1 CD45  gated SP cells were
32.9   9.0% (Fig. 3 B). Thus, ALCAM  cells were en-
riched about fourfold in SP cell population.
Osteo-, Adipo-, and Chondrogenic Differentiation from AL-
CAMhigh Cells. To determine whether perichondrial cells
could differentiate into multiple mesenchymal lineages, we
examined osteoblast, adipocyte, and chondrocyte differen-
Figure 2. Characterization of perichondrial cells. (A) Comparison of proliferation be-
tween freshly isolated ALCAM  and ALCAM  cells. ALCAM  and ALCAM  cells were
sorted from freshly isolated LMCs and plated into 48-well plates at 1.5   104 cells per well.
Cell numbers were determined on days 1–4. (B) Effects of ALCAM-Fc and CD6-Fc on the
cell proliferation. ALCAM  cells were sorted from freshly prepared LMCs, and cultured for
5 d in the presence of various concentrations of Fc-chimeric proteins. The number of ex-
panded cells was counted on days 0.5, 3, and 5. (a) The ratio of cell growth. The cell num-
ber of the 0.5 d of culture in the presence of control-Fc was set at 1.0. (b) The relative cell
numbers on each day of culture. The cell number in cultivation with control-Fc in each
culture period was set as 1.0. The data shown represent the mean  SD. (C) ALCAM  cells
were isolated from freshly prepared LMCs, and the expression of ALCAM was examined on
days 2 and 6 of cultivation. The percentages of ALCAM  cells in each panel are representa-
tive of triplicate experiments. (D) Flow cytometric characterization of ALCAMhigh cells.
The expression of cell surface markers indicated on panels (a–l) was examined by FACS®.1554 Role of Perichondrial Stem Cells in Bone and Bone Marrow Formation
Figure 3. Limb SP cells express ALCAM. (A) LMCs
were stained with Hoechst 33342 and analyzed for ex-
pression of ALCAM, PECAM-1, and CD45 in the SP cell
fraction. (a) Hoechst 33342 staining and emission pattern
of LMCs. SP cells were indicated in the enclosed region.
(b) Hoechst 33342 staining and emission pattern of LMCs
in the presence of verapamil. (B) A fluorescence histogram
shows the ALCAM staining profile of the SP gated with
the PECAM-1 CD45  fraction. The percentages of
ALCAM  cells are representative of triplicate experiments.
Figure 4. Osteoblasts, adipocytes, and
chondrocyte differentiation. (A) Total
LMCs (a, d, and g), ALCAMlow/  cells (b, e,
and h), and ALCAMhigh cells (c, f, and i)
were induced (d–i) or not-induced (a–c) to
undergo osteogenic differentiation. After 2
wk, ALP staining was performed. Panels g–i
show high power fields of d–f, respectively.
Scale bars, 1 mm (a–f), 200  m (g–i). (B)
The region of alizarin red positive calcium
deposition in ALCAMhigh cells, in which os-
teogenic differentiation was induced for 2
wk. (a) no factor; (b and c)  -GP and ascor-
bic acid. (b) The center of culture plate. (c)
The corner of the culture plate. (C) TRAP
activities were measured on day 7 of coculti-
vation of BM derived osteoclast precursor
cells and ALCAMhigh cells, which were in-
duced (hatched bar) or not induced (solid
bar) to undergo osteogenic differentiation in
the presence or absence of 1,25-(OH)2D3
and Dex. The data shown represents the
mean  SD. (D) Results of TRAP staining
of cocultured BM-derived osteoclast precur-
sor cells and ALCAMhigh cells, in which os-
teogenic differentiation was induced.
TRAP-positive multinucleated cells are in-
dicated by arrowheads. (a) no factor; (b) in
the presence of 1,25-(OH)2D3 and Dex.
Scale bar, 100  m. (E) Total LMCs (a and d)
ALCAMlow/  cells (b and e), and ALCAMhigh
cells (c and f) were induced to undergo adi-
pogenic differentiation (as described in Ma-
terials and Methods) and stained with Nile
red. (a–c) control medium; (d–f) MDI me-
dium. Scale bar, 200  m. (F) Alcian blue
staining after chondrogenic induction. Total
LMCs (a and d), ALCAMlow/  cells (b and
e), and ALCAMhigh cells (c and f) were in-
duced to undergo chondrogenic differentia-
tion as described in Materials and Methods.
(a–c) no factor; (d–f) in the presence of
BMP-2. Scale bar, 100  m.1555 Arai et al.
tiation from total LMCs, ALCAMhigh, and ALCAMlow/ 
cells. As shown in Fig. 4 A, ALCAMhigh cells but not AL-
CAMlow/  cells differentiated efficiently into ALP  osteo-
blastic cells in the presence of  -GP and ascorbic acid.
Moreover, after 2 wk of cultivation, alizarin red-positive
calcium deposition was observed in ALCAMhigh cells in
the presence of  -GP and ascorbic acid (Fig. 4 B). Strong
calcium deposition was observed in the corner of culture
plate (Fig. 4 B c). ALCAMhigh cells support osteoclast for-
mation from mouse BM precursor cells. In particular,
when ALCAMhigh cells directed to the osteoblasts, it re-
acted well to 1,25-(OH)2D3 and Dex, and higher TRAP
activity was seen as compared with the cells without pre-
cultivation for osteogenic induction (Fig. 4 C). TRAP 
multinucleated cells were formed on osteoblast differentia-
tion induced ALCAMhigh cells in the presence of 1,25-
(OH)2D3 and Dex (Fig. 4 D, arrowheads). Regarding adi-
pogenic differentiation, fluorescence microscopy showed
that a large number of cells cultured in MDI medium con-
tained lipid droplets in ALCAMhigh fraction, while lipid
accumulation in total LMCs and ALCAMlow/  cells was
very low (Fig. 4 E). Chondrogenic phenotype was evalu-
ated by staining with alcian blue, which stains unmineral-
ized cartilaginous matrix. In the presence of BMP-2, large
amounts of alcian blue stained extracellular matrix were
observed in ALCAMhigh cells (Fig. 4 F f). Although, both
unfractionated LMCs and ALCAMlow/  cells may contain
chondrocytes or prechondrocytes, only LMCs differenti-
ated into chondrocytes, while ALCAMlow/  cells did not.
In addition, the rate of alcian blue positive cartilage matrix
synthesis by LMCs was lower than ALCAMhigh cells (Fig.
4 F d). The morphology of the cells from ALCAMlow/ 
fraction became elongated shape in the presence of BMP-2
(Fig. 4 F e). In addition, differentiations of osteoblast,
adipocyte, and chondrocyte from ALCAMhigh cells were
confirmed by the specific gene expressions corresponding
to each linage. As shown in Fig. 6 A, after inductions of
osteoblasts, adipocytes, and chondrocytes, ALCAMhigh
cells express osteocalcin, PPAR- , SOX9, and type II col-
lagen, respectively. Altogether, these data suggest that AL-
CAMhigh cells can differentiate into osteoblasts, adipocytes,
and chondrocytes.
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ALCAM-mediated Homophilic Adhesion Plays a Part in Os-
teogenic Differentiation. We used FACS® to analyze changes
in expression of ALCAM during osteoblastic differentiation.
The expression of ALCAM was decreased with longer cul-
tivation in  -GP and ascorbic acid (58.9   2.2% for 1 wk
of cultivation and 29.5   4.4% for a 2-wk period) (Fig. 5
A, bottom panel). Although a similar decrease was also ob-
served in a culture without factors, the overall percentage of
ALCAM  cells was higher than in culture with factors
(80.7   0.4% after 1 wk of cultivation and 52.5   4.7%
after 2 wk) (Fig. 5 A, top panel). Next, we analyzed how
ALCAM-mediated cell–cell adhesions participate in mesen-
chymal differentiation of ALCAMhigh cells. To do so, AL-
CAM-Fc or CD6-Fc were added to cultures undergoing
osteogenic differentiation to block ALCAM-mediated cell
adhesion. After 2 wk of cultivation, ALCAM-Fc or CD6-
Fc slightly enhanced ALP expression in ALCAMhigh cells
with or without  -GP and ascorbic acid (Fig. 5 B and C).
We propose that blocking of ALCAM-ALCAM interaction
works auxiliary osteogenic differentiation and may facilitate
migration of osteoprogenitor cells into cartilage.
Development of Stromal Cells that Support Hematopoiesis.
We previously reported that ALCAM-transfected endothe-
lial cells support hematopoiesis (21). The number of imma-
ture nonadherent cells was significantly greater in coculture
of fetal liver HSCs with ALCAM-transfected endothelial
cells compared with coculture with vector-transfected cells.
Moreover, lethally irradiated recipient mice were repopu-
lated by hematopoietic cells cocultured with ALCAM-
transfected endothelial cells, but not with vector-trans-
fected cells. These data suggest that ALCAM might be
involved with maintenance of HSCs or expansion of prim-
itive hematopoietic progenitor cells. In this study, we
analyzed whether ALCAMhigh cells can support hemato-
poietic cell differentiation and growth. BM HSCs were
cultured without feeder layer cells or cocultured with AL-
Figure 5. ALCAM-mediated homophilic adhesion plays a role in osteogenic differentiation. (A) Changes in expression of ALCAM were examined by
FACS® after 1 wk (1 W) and 2 wk (2 W) of osteoblastic differentiation. The percentages of ALCAM  cells in each panel represent triplicate experiments.
(B) Osteogenic differentiation of ALCAMhigh cells was induced in the presence of control-Fc (a and d), ALCAM-Fc (b and e), or CD6-Fc (c and f). After
2 wk of cultivation, all cells were stained by ALP. (a–c) No factor; (d–f) in the presence of  -GP and ascorbic acid. Scale bar, 1 mm. (C) Relative ALP-
activities were measured on day 14 of cultivation. ALP-activity from in the presence of control-Fc alone was set at 1.0. The data shown represents the
mean  SD.1557 Arai et al.
CAMhigh or ALCAMlow/  cells in the presence of SCF, IL-
6, IL-7, and Epo for 8 d. After cocultivation, the number
of CD45  cells was counted and the expressions of c-Kit
and hematopoietic lineage markers (CD4, CD8, B220,
TER-119, Gr-1, and Mac-1) were analyzed (Table I). The
number of CD45  cells was significantly greater in cocul-
ture with ALCAMhigh cells compared with culture without
feeder layer or coculture with ALCAMlow/  cells (Fig. 6
A). Moreover, ALCAMhigh cells efficiently maintained c-Kit
expression (25.8   0.9%) as compared with ALCAMlow/ 
cells (7.3   0.8%) or without feeder layer (4.5   0.5%)
(Fig. 6 B). It indicated that ALCAMhigh cells maintain im-
mature phenotype of HSCs. Further, these data were cor-
responding to our previous report (21). The percentages of
B220  B cells and TER-119  erythroid lineages in AL-
CAMhigh cells (B220 : 11.8   2.0%, TER-119 : 6.1  
5.2%) were also higher than ALCAMlow/  cells (B220 :
4.9   1.6%, TER-119 : 2.8   1.0%). The expressions of
Mac-1 and Gr-1 were not significantly changed between
ALCAMhigh and ALCAMlow/  cells. After BM cavity for-
mation, osteoblasts consist of a part of hematopoietic mi-
croenvironment in BM (32). Therefore, we also examined
hematopoiesis on ALCAMhigh cells that induced to un-
dergo osteoblastic differentiation. On osteoblastic feeder
layer, Mac-1  cells were developed well (93.3   2.4%) as
compared with ALCAMhigh cells (72.3   4.2%). In addi-
tion, the percentage of B220  cells was reduced on osteo-
blastic feeder layer (1.3   0.3%).
Angiogenesis Supporting Activity of Each Lineage. We an-
alyzed angiogenesis supporting ability of perichondrial cells.
First, we examined the expression of angiogenic factors in
ALCAMhigh cells. ALCAMhigh cells were induced to un-
dergo osteo- adipo-, and chondrogenic differentiation and
the expression of Ang1, Ang2, VEGF, bFGF, and chon-
dromodulin-1 (ChM-1) was examined by RT-PCR (Fig.
7 A a). Differentiations of osteoblast, adipocyte, and chon-
drocyte from ALCAMhigh cells were confirmed by the spe-
cific gene expressions, such as osteocalcin (for osteoblast),
PPAR  (for adipocyte),  I type II collagen and SOX9 (for
chondrocyte) (Fig. 7 A b). Before cultivation, ALCAMhigh
cells highly expressed VEGF, bFGF, and Ang2, and faintly
expressed Ang1 and ChM-1. The expression of Ang1 was
increased and Ang2 was decreased during osteogenic, adi-
pogenic, and chondrogenic differentiation. bFGF expres-
sion was slightly increased after osteogenic induction. In
chondrocytes, expression of ChM-1, a known inhibitor of
angiogenesis, was increased. We further analyzed whether
ALCAMhigh cells support endothelial colony formation.
E9.5 P-Sp–derived cells were cultured on various feeder
layers in the presence or absence of VEGF for 10 d. It is
known that the P-Sp region contains hematopoietic stem/
progenitor cells and endothelial progenitor cells or com-
mon progenitors, hemangioblasts (33). Osteoblast and adi-
pocyte layers can support angiogenesis from P-Sp. There
Table I. ALCAMhigh Cells Support the Differentiation of Hematopoietic Cells
Percentage of positive cells
ALCAMlow/  ALCAMhigh ALCAMhigh/osteogenic
CD4 1.2   0.5 1.0   0.1 7.7   1.8
CD8 0.3   0.2 3.8   0.5 6.0   1.2
B220 4.9   1.6 11.8   2.0 1.3   0.3
TER-119 2.8   1.0 6.1   5.2 2.5   0.5
Mac-1 76.3   7.7 72.3   4.2 93.3   2.4
Gr-1 83.9   12.1 62.3   5.8 69.0   1.1
BM-derived Lin c-Kit+Sca-1+ HSCs (500 cells per well) were cocultured with ALCAMlow/ , ALCAMhigh cells, or osteogenic differentiation induced
ALCAMhigh cells (ALCAMhigh/osteogenic) in the presence of SCF, IL-6, IL-7, and Epo. After 8 d of cultivation, the expression of lineage markers
was analyzed by FACS®. The data shown represents the mean  SD.
Figure 6. ALCAMhigh cells support hematopoiesis. Total of 103 Lin-
c-Kit Sca-1  cells were cultured without feeder layer or cocultured with
ALCAMhigh or ALCAMlow/  cells in the presence of SCF, IL-6, IL-7, and
EPO. After 8 d of cultivation, the number of CD45  cell was scored (A),
and expression of c-Kit was analyzed by FACS® (B). The data shown rep-
resents the mean  SD.1558 Role of Perichondrial Stem Cells in Bone and Bone Marrow Formation
was no significant difference in the number of the colonies
formed on osteoblast and adipocyte layers (data not
shown). Although the mechanisms are not known, vascular
network formation on osteoblast layers developed well,
while on adipocyte layers, vascular sheet formation was de-
tected. On the other hand, chondrocyte layers did not sup-
port angiogenesis, possibly due to the expression of ChM-1.
Exogenous VEGF enhanced endothelial cell colony forma-
tion in each feeder layer (Fig. 7 B).
As shown in Fig. 7 C, we compared endothelial net-
work formation between cultivations on calcified or non-
calcified osteoblast layers. When ALCAMhigh cells were
cultured for 1 wk in the presence of  -GP and ascorbic
acid (noncalcified osteoblast layer), fine endothelial net-
work formation was observed in the presence or absence
of VEGF. By contrast, cultivation of ALCAMhigh cells for
1 d in the presence of BMP-4 followed by 6 d in  -GP
and ascorbic acid to promote osteogenic differentiation re-
sulted in strong calcium deposition (calcified osteoblast lay-
ers). On the calcified osteoblast layers, branches of PE-
CAM-1  networks were thicker than on noncalcified
osteoblast layers.
To analyze differences in endothelial cell-supporting ac-
tivity between calcified and noncalcified conditions, the
expression of VEGF, bFGF, Ang1, and Ang2 was exam-
ined. As shown in Fig. 7 D, the expression of bFGF was
downregulated on calcified osteoblasts after treatment with
a combination of BMP-4,  -GP, and ascorbic acid. In con-
trast, VEGF expression was upregulated after treatment
with the same combination compared with treatment with
 -GP and ascorbic acid only. Although other factors may
promote endothelial network formation, higher expression
of VEGF and lower expression bFGF in the calcified feeder
layer are likely related to making thicker branching of en-
dothelial networks.
Function of ALCAM in Vascular Invasion. To analyze
the role of ALCAM-mediated cell-cell interaction for inva-
sion of blood vessels into cartilage, we performed metatar-
sal culture as a model of the vascular invasion, and consid-
ered the function of ALCAM-Fc and CD6-Fc. E17.5
Figure 7. ALCAMhigh cells support growth and differentiation of endothelial cells. (A) Expression of VEGF, bFGF, Ang1, Ang2, and ChM-1 was an-
alyzed by RT-PCR after induction of mesenchymal lineages (a). The expression of mesenchymal lineage markers (b). N, not induced; O, osteogenic; A,
adipogenic; and C, chondrogenic induction. (B) Cocultivation of E9.5 P-Sp–derived cells and ALCAMhigh cells in the presence (e–h) or absence (a–d) of
VEGF. The cells of feeder layers were not induced (a and e) or induced to undergo osteoblast (b and f) adipocyte (c and g), and chondrogenic (d and h)
induction. After 10 d of cultivation, endothelial cells were verified by PECAM-1 reactivity. Scale bar, 500  m. (C) Differences in angiogenesis support-
ive activity between calcified or not-calcified osteogenic differentiation. ALCAMhigh cells were precultured in  -GP and ascorbic acid for 1 wk (not-cal-
cified condition, b and e) or rh-BMP-4 for 1 d, followed by treatment with  -GP and ascorbic acid for an additional 6 d (calcified condition, c and f).
P-Sp–derived cells were cocultured on each feeder layer in the presence (c–f) or absence (a–c) of VEGF. After 10 d of cocultivation, cells were fixed and
stained anti–PECAM-1 mAb. Asterisks indicate a region where calcium deposition appears to occur. Scale bar, 500  m. (D) Expression of VEGF, bFGF,
Ang1, and Ang2 in calcified or not calcified osteogenic induction analyzed by RT-PCR.1559 Arai et al.
mouse three middle metatarsals of hindlimb were dissected
and cultured in 10% FCS/BGJb medium in the presence of
Fc-chimeric protein. After 5 d of cultivation, metatarsals
were fixed and processed for polyester wax sections. Each
section was stained with anti–PECAM-1 mAbs. Before
cultivation, blood vessels enclosed the cartilage, but there
were no invaded PECAM-1  vessels (Fig. 8 A). The addi-
tion of control-Fc to metatarsal culture, there are many
blood vessels that invaded into cartilage were observed
(Fig. 8 B). In contrast, blocking of ALCAM-ALCAM in-
teraction by the addition of ALCAM-Fc and CD6-Fc in-
hibit vascular invasion into the cartilage (Fig. 8 C and D).
Although it is known well that vascular invasion is mainly
controlled by angiogenic factors, it is assumed that AL-
CAM-mediated homophilic cell adhesion may support en-
dothelial cells to adhere to cartilages.
Discussion
Our results provide further characterization of perichon-
drial cells in mouse fetal limb and clarify the functions of
ALCAM for bone and BM formation. Perichondrial cells
were isolated by FACS® using an anti-ALCAM mAb.
These cells exhibited the characteristics of MSCs and were
directed into restricted terminal differentiation pathways,
such as osteogenic, adipogenic, chondrogenic, and stromal
lineages (Fig. 9 A).
Multipotential Nature of ALCAMhigh Cells. Previous ex-
periments have shown that MSCs isolated from adult BM
were characterized by their potential to proliferate in cul-
ture, by their multilineage differentiation ability and by the
presence of a consistent set of marker proteins (5, 34). In
this paper, we analyzed embryonic MSCs. Although the
adult mesenchymal progenitor cells may be phenotypically
different from embryonic ones, the former follows the early
ontogeny. Data presented here suggests that the multipo-
tential nature of perichondrial cells fits with many of the
functional requirements described for MSCs (35, 36). AL-
CAM expression was localized to the perichondrium and
endothelial cells. PECAM-1  gating excluded ALCAM 
endothelial cells of fetal limb (Fig. 1). ALCAMhigh cells
showed multiple differentiation capacity, such as osteo-,
adipo-, chondrogenic, and stromal differentiation (Figs. 4–7).
Although total LMCs consisted largely of chondrocytes,
the rate of cartilage matrix synthesis without BMP-2 was
lower than ALCAMhigh cells. It is thought that LMC was
not able to maintain differentiation ability of a chondrocyte
during precultivation. Our results strongly suggest that
MSCs exist in the perichondrium, and existence of MSCs
in perichondrial region may be reasonable for both bone
collar formation and supplement of osteoprogenitor cells
into cartilage during endochondral ossification.
In addition, recent studies have described methods for
identifying pluripotent stem cells, also called SP cells, from
many tissues based on Hoechst 33342-dye efflux (37, 38).
Purified SP cells derived from adult skeletal muscle, for ex-
ample, have the capacity to differentiate into all major he-
matopoietic lineages after transplantation into lethally irradi-
ated mice (39). In our studies, Hoechst staining showed that
ALCAM  cells existed in SP cells in fetal limb (Fig. 3 B), in-
dicating that pluripotent stem cells exist in fetal limb. Alto-
gether, these results suggest that ALCAM is a good marker
of MSCs in developing limb. The data demonstrate that cells
of the perichondrium layer contain MSCs and that sorted
ALCAMhigh cells are a fairly homogeneous population (Fig.
2 C). Further clonal assays may be necessary to fully charac-
terize perichondrial cells. In addition, Reyes et al. (40) re-
ported that human BM-derived mesodermal progenitor cells
(MPCs) that can differentiated into not only mesenchymal
lineage (osteoblasts, adipocytes, chondrocytes, and skeletal
Figure 8. ALCAM-Fc and CD6-Fc in-
hibit vascular invasion into cartilage. PE-
CAM-1 immunohistochemical staining of
metatarsal culture sections. E17.5 mouse
three middle metatarsals of hind limb were
dissected and cultured for 5 d in 10% FCS/
BGJb medium in the presence of Fc-chi-
meric protein (A) before cultivation. (B)
control-Fc. (C) CD6-Fc. (D) ALCAM-Fc.
The dotted line indicates the margin of car-
tilage. Scale bar, 100  m. Representative
data from independent three experiments
are shown.1560 Role of Perichondrial Stem Cells in Bone and Bone Marrow Formation
muscle cells) but also endothelial cells. It is interesting that
the analysis of the plasticity of MSCs in perichondrium.
Function of ALCAM in MSCs. It is known that mainte-
nance of undifferentiated nature and differentiation of the
cell is closely related to cell density (40). To establish and
maintain the MSCs, some cell density or cell–cell interac-
tion might be required. Thus, we take notice of a cell ad-
hesion molecule, or ALCAM. We have previously re-
ported that homophilic adhesion through ALCAM is
involved with maintenance of HSCs or expansion of prim-
itive hematopoietic progenitor cells. In addition, ALCAM
plays a critical role in growth of ALCAM  endothelial pre-
cursor cells (21). ALCAMhigh cells but not ALCAMlow/ 
cells could differentiated into multiple lineage differentia-
tion (Fig. 4).
We hypothesize that ALCAM-mediated homophilic cell
adhesion plays a role in the maintenance of multipotency
of perichondrial cells. Furthermore, the freshly isolated
ALCAM  cells showed higher proliferative activities than
the freshly isolated ALCAM  cells (Fig. 2 A), and the pro-
liferation of ALCAM  cells was partially inhibited by the
addition of ALCAM-Fc and CD6-Fc (Fig. 2 B), it was sug-
gested that the ALCAM-mediated cell–cell interaction
works auxiliary to the proliferation of perichondrial cells
(Fig. 9 B). ALCAM expression increased in ALCAM  cells
which were isolated from freshly prepared LMCs, and de-
creased after induction of osteogenic differentiation in AL-
CAMhigh cells (Figs. 2 C and 5 A). Since osteoblast is one of
the terminally differentiated cells in mesenchymal lineages,
we suppose that these changes of ALCAM expression are
irreversible in perichondrial cells.
In addition, when ALCAM-mediated homophilic inter-
action was blocked by addition of ALCAM-Fc or CD6-Fc,
the osteoblastic differentiation from ALCAMhigh cells was
promoted (Fig. 5 B). Bruder et al. (10) also reported that
addition of ALCAM Fab fragments to human MSCs under-
Figure 9. Model of multipotency of ALCAM  peri-
chondrial cells and the function of ALCAM in the peri-
chondrium. (A) ALCAM  perichondrial cells differenti-
ate into osteo-, adipo-, chondro-, and stromal cell lineages
and support osteoclastogenesis, hematopoiesis, and an-
giogenesis. VEGF, bFGF, and Ang1, which are ex-
pressed by stromal cells, osteoblasts, adipocytes, and hy-
pertrophic chondrocytes, promote angiogenesis. ChM-1,
which is expressed by immature chondrocytes, inhibits
angiogenesis. Osteoblasts support osteoclastogenesis by
the expression of RANKL and M-CSF. (B, 1) ALCAM-
mediated homophilic cell-cell adhesion supports cell
growth and maintenance of multipotency. (2) ALCAM-
mediated cell adhesion between perichondrial cells and
endothelial cells attracts vessels to cartilage. (3) Loss of
ALCAM–ALCAM interaction or downregulation of
ALCAM assists osteogenic differentiation and may facili-
tate migration of osteoprogenitor cells into cartilage.1561 Arai et al.
going osteogenic differentiation in vitro elevated the level
and accelerated the onset of ALP expression and mineral
deposition during osteogenesis. Although it is not known
whether the ALCAM-mediated cell–cell interaction has
controlled osteoblastic differentiation directly or indirectly,
our data suggests that interfering with ALCAM–ALCAM
interaction supports to differentiation of MSCs into osteo-
blasts (Fig. 9 B). Altogether, our results suggest the possibil-
ity that ALCAM-mediated homophilic cell adhesion assists
to both maintaining the multipotentiality and lineage spe-
cific differentiation of MSCs of the perichondrium.
Contribution of Perichondrial Cells to Bone and BM Forma-
tion. Final goal of this investigation is to understand the
mechanisms of bone and bone marrow formation through
the analyses for the differentiation of mesenchymal cells,
angiogenesis, and hematopoiesis. During endochondral os-
sification, MSCs in the perichondrium may play multiple
roles. In the mouse humerus, the process of differentiation
of osteoblasts in the perichondrium is initiated at approxi-
mately E13.5 and deposition of the bone collar takes place
until E14.5 (41). Ossification begins with invasion of the
calcified hypertrophic cartilage by capillaries, accompanied
by apoptosis of terminal hypertrophic chondrocytes, degra-
dation of cartilage matrix, and deposition of bone matrix by
osteoblasts. Remodeling of bone matrix by osteoclasts re-
sults in a cavity filled with vessels containing hematopoietic
cells. During this process, osteoblast progenitor cells are
supplied by the perichondrium. Loss of ALCAM–ALCAM
interaction may promote both osteoblastic differentiation
and migration of osteoprogenitor cells into the inner peri-
osteal layer (Fig. 9 B).
The process of vascular invasion is mainly regulated by
an angiogenic factor–dependent pathway (42). It is well
known that VEGF, bFGF, and Ang1 enhance angiogenesis
and that VEGF and bFGF synergistically control angiogen-
esis (43). Ang2 is an antagonist of Ang1. Hypertrophic car-
tilage may produce angiogenic activators, such as VEGF,
whereas other types of cartilage produce angiogenic inhibi-
tors such as ChM-1 (44). A delicate balance between the
rate of formation of calcified cartilage and its vascularization
must be maintained in order for bone development to pro-
ceed normally. Recently, it was reported that VEGF, Ang1,
and Ang2 were coexpressed in hypertrophic chondrocytes,
osteoblasts, osteoclasts, and perichondrium in human neo-
natal ribs (45). Furthermore, the expression of these factors
is highest at sites of bone collar formation and colocalizes
with ALP expression (45). Such distribution of Angs and
VEGF indicate that these factors might play key roles in the
regulation of vascular invasion into cartilage during endo-
chondral ossification. As shown in Fig. 7 A, expression of
Ang1 increased and Ang2 decreased during lineage-specific
differentiation. Moreover, after induction of osteoblastic
differentiation, ALCAMhigh  cells supported formation of
fine vascular networks. In addition, vascular networks on
calcified osteoblast layers were thicker than on noncalcified
osteoblast layers. This observation is consisted with the idea
that vascular invasion occurs after calcification of bone col-
lar. Takeda et al. (46) reported that cbfa1, also known as
AML3 or Pebp2 A, is expressed in the perichondrium and
regulates osteoblast differentiation, and cbfa1-deficient mice
do not show chondrocyte hypertrophy and vascular inva-
sion. The expression pattern of cbfa1 corresponds to the
expression of VEGF, Ang1, and Ang2, which suggests the
possibility that osteoblastic differentiation of MSCs regu-
lates the expression of angiogenic factors. In addition, AL-
CAMhigh cells support osteoclast formation. Osteoclasts al-
low blood capillaries to penetrate into cartilage and lead to
formation of the marrow space. May-Grünwald Giemsa
staining revealed that most of ALCAM  hematopoi-
etic cells (PECAM-1 CD45 ALCAM  cells) in cultivated
LMCs (Fig. 1 B, right panel) were the monocyte-macro-
phage lineage (data not shown). It is possible that these mono-
cyte-macrophage lineage cells differentiate into osteoclasts.
Furthermore, the metatarsal culture revealed that ALCAM-
Fc and CD6-Fc inhibit vascular invasion into the cartilage
(Fig. 8 C and D). The homophilic cell adhesion through
ALCAM between perichondrial cells and endothelial cells
may promote blood vessels to adhere to a cartilage (Fig. 8
B). In addition, ALCAM was found to be involved in cap-
illary tube formation and hemangioblast differentiation
(21). These observations suggest that perichondrium sup-
plies osteoblast progenitor cells and stromal cells, and plays a
positive role in vascular invasion through not only the pro-
duction of angiogenesis-inducible factors but also promo-
tion of adhesion of endothelial cells to cartilage.
In conclusion, we have identified ALCAM  MSCs in
perichondrium and clarified the role of ALCAM in early
bone development. The perichondrium might serve as a
MSC reservoir and play a critical role in endochondral ossi-
fication and BM formation in fetal limb.
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